✦ LIBER ✦

Control of Chemotherapy-Induced Emesis with 5-Hydroxytryptamine-3 Antagonists

✍ Scribed by Price, Nancy; Jain, Vinay K.

Book ID: 122758716
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 79 KB
Volume: 1
Category: Article
ISSN: 1543-2912
DOI: 10.1016/S1543-2912(13)60090-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Hydroxytryptamine3 receptor antagonist

5-Hydroxytryptamine3 receptor antagonists inhibit enterotoxin B-induced emesis in the ferret

✍ A. Sagrada; C.A. Rizzi; P. Bonali; A. Donetti 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 154 KB

5-Hydroxytryptamine (serotonin) subtype

5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis

✍ K. Bremer 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 339 KB

5-hydroxytryptamine type-3 receptor anta

5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis : Can we safely reduce the dose of administered agents?

✍ Matti Aapro; Peter Blower 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

Supported by Roche Laboratories. Dr. Blower has acted as a consultant to Glaxo-SmithKline, Novartis Pharma, and Hoffman-La Roche Laboratories and is a stockholder for Glaxo-SmithKline. Dr. Aapro has acted as a consultant for Roche Laboratories, Helsinn, Novartis Pharma, and Aventis, all of which a

PP37. Pharmacoeconomic analysis of the a

PP37. Pharmacoeconomic analysis of the antagonists 5-HT3 in the control of chemotherapy-induced emesis in children

✍ M Jiménez Monteagudo; J Carrera; P León; J Gimeno; L Sierrasesúmaga 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 165 KB

FIRST RESULTS WITH ICS 205-930 (5-HT3 RE

FIRST RESULTS WITH ICS 205-930 (5-HT3 RECEPTOR ANTAGONIST) IN PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS

✍ Leibundgut, U; Lancranjan, I 📂 Article 📅 1987 🏛 The Lancet 🌐 English ⚖ 186 KB

Does Pharmacogenomics Account for Variab

Does Pharmacogenomics Account for Variability in Control of Acute Chemotherapy-Induced Nausea and Vomiting with 5-Hydroxytryptamine Type 3 Receptor Antagonists?

✍ Trammel, Morgan; Roederer, Mary; Patel, Jai; McLeod, Howard 📂 Article 📅 2013 🏛 Current Science Inc. 🌐 English ⚖ 279 KB